150 related articles for article (PubMed ID: 10348139)
1. Combined use of Orgaran and Reopro during coronary angioplasty in patients unable to receive heparin.
Cantor WJ; Leblanc K; Garvey B; Watson KR; Rasymas A; Strauss BH
Catheter Cardiovasc Interv; 1999 Mar; 46(3):352-5. PubMed ID: 10348139
[TBL] [Abstract][Full Text] [Related]
2. Options to heparin anticoagulation for cardiac interventions.
Kahn JK
Catheter Cardiovasc Interv; 1999 Mar; 46(3):356. PubMed ID: 10348140
[No Abstract] [Full Text] [Related]
3. Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia.
Hale LP; Smith K; Braden GA; Owen J
Cathet Cardiovasc Diagn; 1998 Nov; 45(3):318-22. PubMed ID: 9829897
[TBL] [Abstract][Full Text] [Related]
4. [Thrombocytopenia due to heparin therapy. Use of danaparoid (Orgaran), 13 monocentric cases under authorization of temporary prescription (ATU)].
Gindre L; de Maistre E; Perrin A; Lecompte T; Hoffman MA
Therapie; 1997; 52(6):591-7. PubMed ID: 9734113
[TBL] [Abstract][Full Text] [Related]
5. Heparinoid anticoagulation and topical fibrin sealant in heparin-induced thrombocytopenia.
Jackson MR; Danby CA; Alving BM
Ann Thorac Surg; 1997 Dec; 64(6):1815-7. PubMed ID: 9436582
[TBL] [Abstract][Full Text] [Related]
6. The use of low dose Orgaran in heparin-induced thrombocytopenia associated with in vitro platelet aggregation at higher Orgaran concentrations.
Hill GR; Hickton C; Henderson S; Patton WN
Clin Lab Haematol; 1997 Jun; 19(2):155-7. PubMed ID: 9218159
[TBL] [Abstract][Full Text] [Related]
7. Treatment of heparin-induced thrombocytopenia.
Peters FP
J Thorac Cardiovasc Surg; 1997 Sep; 114(3):517-8. PubMed ID: 9305220
[No Abstract] [Full Text] [Related]
8. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172).
Magnani HN
Thromb Haemost; 1993 Oct; 70(4):554-61. PubMed ID: 7509508
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
Westphal K; Martens S; Strouhal U; Matheis G; Lindhoff-Last E; Wimmer-Greinecker G; Lischke V
Thorac Cardiovasc Surg; 1997 Dec; 45(6):318-20. PubMed ID: 9477469
[TBL] [Abstract][Full Text] [Related]
10. [Value of orgaran in hemodialysis during heparin-induced thrombopenia].
Lamriben L; Tiberghien F; Delacour JL; Floriot C; Wagschal G; Daoudal P; Ory JP
Presse Med; 1996 Sep; 25(28):1303. PubMed ID: 8949796
[No Abstract] [Full Text] [Related]
11. [Heparin-induced thrombopenia during hemodialysis in intensive care: use of a low molecular weight heparinoid, ORG 10172 (Orgaran)].
Mahul P; Raynaud J; Favre JP; Jospé R; Décousus H; Auboyer C
Ann Fr Anesth Reanim; 1995; 14(1):29-32. PubMed ID: 7677282
[TBL] [Abstract][Full Text] [Related]
12. Vascular drugs in the new millennium.
Frangos SG; Chen AH; Sumpio B
J Am Coll Surg; 2000 Jul; 191(1):76-92. PubMed ID: 10898187
[No Abstract] [Full Text] [Related]
13. Failure of Orgaran therapy in a patient with a previous heparin-induced thrombocytopenia syndrome.
Tardy/Poncet B; Mahul P; Beraud AM; Favre JP; Tardy B; Guyotat D
Br J Haematol; 1995 Aug; 90(4):969-70. PubMed ID: 7669684
[No Abstract] [Full Text] [Related]
14. [Use of Organon, a synthetic heparinoid, in two cardiopulmonary bypass procedures in the same patient sensitive to heparin].
Pineau E; Le Bret E; Folliguet T; Saint Maurice OS; Carbognani D; Laborde F
Arch Mal Coeur Vaiss; 2001 Feb; 94(2):144-7. PubMed ID: 11265553
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia type II: successful use of Orgaran (ORG 10172) in intensive care patients.
Burkhard-Meier U; Söhngen D; Schultheiss HP; Greinacher A; Schwartzkopff B; Vogt M; Heyll A; Schneider W
Intensive Care Med; 1995 Jun; 21(6):542-3. PubMed ID: 7560499
[No Abstract] [Full Text] [Related]
16. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results.
Popma JJ; Satler LF
J Invasive Cardiol; 1994; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090
[TBL] [Abstract][Full Text] [Related]
17. [Danaparoid (orgaran) for continuous venovenous hemodiafiltration in a patient with heparin-induced thrombocytopenia].
Christin F; Theissen-Laval O; Loeb JP
Ann Fr Anesth Reanim; 1998; 17(1):82-3. PubMed ID: 9750692
[No Abstract] [Full Text] [Related]
18. [Heparin-induced thrombopenia and thrombosis].
Stöckli TC; Walther A; Görres G; Ritz R; Marbet GA
Schweiz Med Wochenschr; 1996 Mar; 126(12):483-8. PubMed ID: 8650513
[TBL] [Abstract][Full Text] [Related]
19. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
von Segesser LK; Mueller X; Marty B; Horisberger J; Corno A
Perfusion; 2001 Sep; 16(5):411-6. PubMed ID: 11565896
[TBL] [Abstract][Full Text] [Related]
20. [Use of Orgaran for extracorporeal circulation in a patient allergic to heparin].
Bretelle C; Leude E; Quilici J; Vaillant A
Presse Med; 1996 Nov; 25(37):1846-7. PubMed ID: 8991040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
